Increasing the immune activity of exosomes: the effect of miRNA-depleted exosome proteins on activating dendritic cell/cytokine-induced killer cells against pancreatic cancer.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 27143262)

Published in J Zhejiang Univ Sci B on May 01, 2016

Authors

Ri-Sheng Que1, Cheng Lin2, Guo-Ping Ding2, Zheng-Rong Wu2, Li-Ping Cao2

Author Affiliations

1: Department of Surgery, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China.
2: Department of Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou 310020, China.

Articles cited by this

Pancreatic cancer. Lancet (2011) 8.54

Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med (2001) 5.71

Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell (2014) 4.53

Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. Cancer Cell (2014) 2.90

Treatment of metastatic pancreatic adenocarcinoma: a review. Oncology (Williston Park) (2014) 2.48

Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review. Cancer Metastasis Rev (2013) 2.46

Comparative proteomics evaluation of plasma exosome isolation techniques and assessment of the stability of exosomes in normal human blood plasma. Proteomics (2013) 1.93

Purification, characterization and biological significance of tumor-derived exosomes. Anticancer Res (2005) 1.77

Improvement of surgical results for pancreatic cancer. Lancet Oncol (2013) 1.60

Tumour-derived microvesicles modulate biological activity of human monocytes. Immunol Lett (2007) 1.43

Multifunctional roles of gelsolin in health and diseases. Med Res Rev (2010) 1.42

miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor. Biochem Biophys Res Commun (2011) 1.42

Isolation of biologically-active exosomes from human plasma. J Immunol Methods (2014) 1.35

The application of exosomes as a nanoscale cancer vaccine. Int J Nanomedicine (2010) 1.18

Distribution and lateral mobility of DC-SIGN on immature dendritic cells--implications for pathogen uptake. J Cell Sci (2008) 1.12

Can the dual-functional capability of CIK cells be used to improve antitumor effects? Cell Immunol (2013) 1.10

Dendritic cell-derived exosomes as immunotherapies in the fight against cancer. J Immunol (2014) 1.05

Isolation and characterization of CD34+ blast-derived exosomes in acute myeloid leukemia. PLoS One (2014) 0.99

Pancreatic cancer derived exosomes regulate the expression of TLR4 in dendritic cells via miR-203. Cell Immunol (2014) 0.99

Phase II clinical trial of ex vivo-expanded cytokine-induced killer cells therapy in advanced pancreatic cancer. Cancer Immunol Immunother (2014) 0.98

miR-212 promotes pancreatic cancer cell growth and invasion by targeting the hedgehog signaling pathway receptor patched-1. J Exp Clin Cancer Res (2014) 0.98

Attractin: a cub-family protease involved in T cell-monocyte/macrophage interactions. Adv Exp Med Biol (2000) 0.98

Autologous dendritic cell based adoptive immunotherapy of patients with colorectal cancer-A phase I-II study. Pathol Oncol Res (2013) 0.86